Screener
Praxis Precision Medicines, Inc. PRAX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $474,761 | $357,329 |
| Marketable securities | 283,790 | 242,002 |
| Prepaid expenses and other current assets | 13,352 | 11,580 |
| Total current assets | 771,903 | 610,911 |
| Long-term marketable securities | 615,290 | 326,757 |
| Property and equipment, net | 492 | 147 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s short-term investments?
- Praxis Precision Medicines, Inc. (PRAX) reported short-term investments of $283.79M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s short-term investments changed year-over-year?
- Praxis Precision Medicines, Inc.'s short-term investments increased by 97.3% year-over-year, from $143.86M to $283.79M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s short-term investments has grown at a 23.0% compound annual growth rate (CAGR), from $105.68M to $242M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Praxis Precision Medicines, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude